We are live on !
Find out more
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter Est. Return
+29.51%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$16.3B
AUM Growth
+$2.23B
(+16%)
Cap. Flow
-$15.3M
Cap. Flow % of AUM
Cap. Flow %
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
37.34%
Holding
1,883
New
197
Increased
1,009
Reduced
634
Closed
42
Avg Time Held
3.4
years
Top 10 Avg Time Held
4.7
years
Top 20 Avg Time Held
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$80.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$76.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$57.8M |
| 4 |
Caterpillar
CAT
|
+$32.2M |
| 5 |
Applied Materials
AMAT
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$149M |
| 2 |
Amazon
AMZN
|
+$128M |
| 3 |
Microsoft
MSFT
|
+$121M |
| 4 |
AbbVie
ABBV
|
+$34.6M |
| 5 |
Costco
COST
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.2% |
| 2 | Communication Services | 10.83% |
| 3 | Financials | 10.29% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
NIO
NIO
$8.47B
| $216K | ﹤0.01% |
42,641
+8,213
| +24% | +$47.8K |
2025 Q1
5 quarters
|
|
1577
Freshworks
FRSH
$3.69B
| $215K | ﹤0.01% |
21,206
+2,077
| +11% | +$18.5K |
2024 Q2
8 quarters
|
|
1578
Enliven Therapeutics
ELVN
$2.81B
| $214K | ﹤0.01% |
+4,225
| New | +$179K |
2026 Q2
0 quarters
|
|
1579
Webull Corp
BULL
$3.19B
| $214K | ﹤0.01% |
32,857
+8,030
| +32% | +$52K |
2025 Q4
2 quarters
|
|
1580
Immunome
IMNM
$1.97B
| $214K | ﹤0.01% |
10,103
+718
| +8% | +$15.4K |
2026 Q1
1 quarter
|
|
1581
Agios Pharmaceuticals
AGIO
$2.04B
| $214K | ﹤0.01% |
+5,757
| New | +$175K |
2026 Q2
0 quarters
|
|
1582
SOLV Energy Inc
MWH
$4.83B
| $213K | ﹤0.01% |
+6,257
| New | +$227K |
2026 Q2
0 quarters
|
|
1583
Stepan Co
SCL
$1.41B
| $212K | ﹤0.01% |
+3,798
| New | +$198K |
2026 Q2
0 quarters
|
|
1584
BioCryst Pharmaceuticals
BCRX
$2.05B
| $211K | ﹤0.01% |
21,137
| – | – |
2022 Q2
16 quarters
|
|
1585
Sunstone Hotel Investors
SHO
$2.19B
| $210K | ﹤0.01% |
18,370
+840
| +5% | +$8.82K |
2021 Q2
20 quarters
|
|
1586
Adient
ADNT
$1.37B
| $210K | ﹤0.01% |
11,415
+317
| +3% | +$6.78K |
2020 Q2
24 quarters
|
|
1587
NETSTREIT Corp
NTST
$1.69B
| $210K | ﹤0.01% |
+9,924
| New | +$201K |
2026 Q2
0 quarters
|
|
1588
Interface
TILE
$2.07B
| $209K | ﹤0.01% |
+5,827
| New | +$170K |
2026 Q2
0 quarters
|
|
1589
Pediatrix Medical
MD
$2.24B
| $208K | ﹤0.01% |
+8,215
| New | +$187K |
2026 Q2
0 quarters
|
|
1590
Uniti Group
UNIT
$1.33B
| $208K | ﹤0.01% |
18,136
+933
| +5% | +$10.6K |
2022 Q2
16 quarters
|
|
1591
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.38B
| $208K | ﹤0.01% |
+6,964
| New | +$230K |
2026 Q2
0 quarters
|
|
1592
Freshpet
FRPT
$3.17B
| $207K | ﹤0.01% |
3,505
-1,281
| -27% | -$73.3K |
2025 Q4
2 quarters
|
|
1593
Albany International
AIN
$1.74B
| $207K | ﹤0.01% |
+2,778
| New | +$174K |
2026 Q2
0 quarters
|
|
1594
SPS Commerce
SPSC
$3.08B
| $206K | ﹤0.01% |
+3,599
| New | +$199K |
2026 Q2
0 quarters
|
|
1595
People Inc
PPLI
$2.86B
| $206K | ﹤0.01% |
+4,453
| New | +$190K |
2026 Q2
0 quarters
|
|
1596
Innospec
IOSP
$2.41B
| $204K | ﹤0.01% |
+2,512
| New | +$199K |
2026 Q2
0 quarters
|
|
1597
Flywire
FLYW
$2.25B
| $204K | ﹤0.01% |
11,598
+813
| +8% | +$12K |
2026 Q1
1 quarter
|
|
1598
GSK
GSK
$99.4B
| $204K | ﹤0.01% |
+3,883
| New | +$205K |
2026 Q2
0 quarters
|
|
1599
Horace Mann Educators
HMN
$1.88B
| $203K | ﹤0.01% |
+3,939
| New | +$183K |
2026 Q2
0 quarters
|
|
1600
OFG Bancorp
OFG
$2.2B
| $203K | ﹤0.01% |
+4,138
| New | +$188K |
2026 Q2
0 quarters
|
|
Similar funds
NMO
Xponance's Q2 2026 Portfolio in Review
As of Q2 2026, Xponance held 1,883 positions worth $16.3B, up 16% from $14.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Xponance's Q2 2026 filing shows 197 new, 1,009 increased, 634 reduced and 42 closed positions. Its largest new stake was SpaceX: 114,259 shares worth $19.5M. The largest sale was Apple, an estimated $149M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Communication Services and Financials.
- Xponance's largest Q2 2026 buy was SpaceX: 114,259 shares worth $19.5M.
- Xponance added most to Micron Technology in Q2 2026, an estimated $80.6M increase.
- Xponance's biggest Q2 2026 reduction was Apple, cutting an estimated $149M.
- Xponance fully exited Coterra Energy in Q2 2026, selling an estimated $4.27M.
- Xponance's ten largest holdings make up 37% of its $16.3B portfolio in Q2 2026.
- Xponance opened 197 new positions and closed 42 in Q2 2026.
- Xponance's portfolio value rose 16% quarter-over-quarter to $16.3B.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.